To assess the clinical efficacy of ALC in the treatment of severe hepatic encephalopathy (grade 3 of the West Haven grading scale), we performed a randomised, double blind placebo-controlled study administering ALC to cirrhotic patients, evaluating the effects on ammonia levels and performance in cognitive functions.
Study Type
INTERVENTIONAL
2g per day
twice per day
Cannizzaro Hospital
Catania, Italy
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.